Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors

Clinical trial NCT05902520 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05902520
Sponsor: AgonOx, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

HNSCC Melanoma Gynecologic Cancer Colorectal Cancer Lung Cancer Urogenital Cancer

Start date: 2023-06-19
Primary completion: 2026-12-31
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.